1.4.1.B2	A179S/E310G/G323S/H328N	mutant exhibited an about 200 times enhanced activity towards substrate (R)-beta-homomethionine compared to mutant E310G and increased activities with (S)-beta-homolysine, (S)-beta-aminobutyric acid, (R)-beta-phenylalanine, (S)-beta-homophenylalanine	762604	
1.4.1.B2	D177A	0.15% of wild-type activity towards L-erythro-3,5-diaminohexanoate	-, 762604	
1.4.1.B2	D177E	7% of wild-type activity towards L-erythro-3,5-diaminohexanoate	762604	
1.4.1.B2	D177H	0.1% of wild-type activity towards L-erythro-3,5-diaminohexanoate	762604	
1.4.1.B2	D177K	almost complete loss of activity towards L-erythro-3,5-diaminohexanoate	762604	
1.4.1.B2	D177N	0.15% of wild-type activity towards L-erythro-3,5-diaminohexanoate	-, 762604	
1.4.1.B2	D177R	0.5% of wild-type activity towards L-erythro-3,5-diaminohexanoate	762604	
1.4.1.B2	D49A	loss of activity towards L-erythro-3,5-diaminohexanoate	-, 762604	
1.4.1.B2	D49E	0.1% of wild-type activity towards L-erythro-3,5-diaminohexanoate	762604	
1.4.1.B2	D49N	less than 0.1% of wild-type activity towards L-erythro-3,5-diaminohexanoate	-, 762604